Burcon Nutrascience Corporation
BU.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.07M | 580.30K | 350.70K | 276.30K | 246.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.07M | 580.30K | 350.70K | 276.30K | 246.50K |
| Cost of Revenue | 4.90M | 3.43M | 2.02M | 890.60K | 477.70K |
| Gross Profit | -3.83M | -2.85M | -1.67M | -614.20K | -231.20K |
| SG&A Expenses | 2.25M | 2.39M | 2.52M | 2.81M | 3.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.23M | 7.11M | 6.39M | 5.81M | 5.78M |
| Operating Income | -7.16M | -6.53M | -6.04M | -5.54M | -5.53M |
| Income Before Tax | -9.26M | -7.97M | -7.09M | -5.94M | -5.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.26 | -7.97 | -7.09 | -5.94 | -5.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.26M | -7.97M | -7.09M | -5.94M | -5.90M |
| EBIT | -7.16M | -6.53M | -6.04M | -5.54M | -5.53M |
| EBITDA | -6.27M | -6.35M | -5.85M | -5.35M | -5.33M |
| EPS Basic | -0.76 | -0.74 | -0.78 | -0.77 | -0.86 |
| Normalized Basic EPS | -0.48 | -0.46 | -0.49 | -0.48 | -0.54 |
| EPS Diluted | -0.76 | -0.74 | -0.78 | -0.77 | -0.86 |
| Normalized Diluted EPS | -0.48 | -0.46 | -0.49 | -0.48 | -0.54 |
| Average Basic Shares Outstanding | 48.00M | 42.44M | 36.86M | 31.28M | 27.65M |
| Average Diluted Shares Outstanding | 48.00M | 42.44M | 36.86M | 31.28M | 27.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |